Search

Your search keyword '"Georgia Papadaki"' showing total 2 results
Start Over Author "Georgia Papadaki" Publisher public library of science (plos)
2 results on '"Georgia Papadaki"'

1. Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).

Author

Andriana I Papaioannou, Konstantinos Kostikas, Effrosyni D Manali, Georgia Papadaki, Aneza Roussou, Aris Spathis, Argyro Mazioti, Ioannis Tomos, Ilias Papanikolaou, Stelios Loukides, Kyriakos Chainis, Petros Karakitsos, Matthias Griese, and Spyros Papiris

Subjects
Medicine, Science
Abstract

Emphysema and idiopathic pulmonary fibrosis (IPF) present either per se or coexist in combined pulmonary fibrosis and emphysema (CPFE). Serum surfactant proteins (SPs) A, B, C and D levels may reflect lung damage. We evaluated serum SP levels in healthy controls, emphysema, IPF, and CPFE patients and their associations to disease severity and survival.122 consecutive patients (31 emphysema, 62 IPF, and 29 CPFE) and 25 healthy controls underwent PFTs, ABG-measurements, 6MWT and chest HRCT. Serum levels of SPs were measured. Patients were followed-up for 1-year.SP-A and SP-D levels differed between groups (p = 0.006 and p

Published
2016
Full Text
View/download PDF

2. Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)

Author

Ioannis Tomos, Effrosyni D. Manali, Georgia Papadaki, Kyriakos Chainis, Ilias Papanikolaou, Konstantinos Kostikas, Stelios Loukides, Matthias Griese, Argyro Mazioti, Spyros Papiris, Aris Spathis, Andriana I. Papaioannou, Petros Karakitsos, and Aneza Roussou

Subjects
Thin-Layer Chromatography, Male, Pathology, Serum Proteins, Pulmonology, Pulmonary Fibrosis, Surfactants, Pulmonary Function, lcsh:Medicine, Kaplan-Meier Estimate, Pathology and Laboratory Medicine, Gastroenterology, Biochemistry, Pulmonary function testing, Idiopathic pulmonary fibrosis, 0302 clinical medicine, Fibrosis, Pulmonary fibrosis, Medicine and Health Sciences, Medicine, 030212 general & internal medicine, Diffuse alveolar damage, lcsh:Science, Multidisciplinary, Chromatographic Techniques, Smoking, Middle Aged, respiratory system, Prognosis, Combined pulmonary fibrosis and emphysema, Blood proteins, Respiratory Function Tests, medicine.anatomical_structure, Phenotype, Pulmonary Emphysema, Physical Sciences, Female, Research Article, medicine.medical_specialty, Pulmonary Surfactant-Associated Proteins, Chronic Obstructive Pulmonary Disease, Materials Science, Research and Analysis Methods, 03 medical and health sciences, Signs and Symptoms, Diagnostic Medicine, Internal medicine, Humans, Materials by Attribute, Aged, Emphysema, Lung, business.industry, lcsh:R, Biology and Life Sciences, Proteins, medicine.disease, respiratory tract diseases, Planar Chromatography, 030228 respiratory system, Physical Fitness, Case-Control Studies, Lesions, lcsh:Q, business, Developmental Biology, Follow-Up Studies
Abstract

Introduction Emphysema and idiopathic pulmonary fibrosis (IPF) present either per se or coexist in combined pulmonary fibrosis and emphysema (CPFE). Serum surfactant proteins (SPs) A, B, C and D levels may reflect lung damage. We evaluated serum SP levels in healthy controls, emphysema, IPF, and CPFE patients and their associations to disease severity and survival. Methods 122 consecutive patients (31 emphysema, 62 IPF, and 29 CPFE) and 25 healthy controls underwent PFTs, ABG-measurements, 6MWT and chest HRCT. Serum levels of SPs were measured. Patients were followed-up for 1-year. Results SP-A and SP-D levels differed between groups (p = 0.006 and p

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results